<DOC>
	<DOCNO>NCT01490567</DOCNO>
	<brief_summary>The objective study study effect donepezil cognition patient schizophrenia . The investigator conduct 12-week , double-blind , placebo-controlled trial donepezil adjunctive treatment antipsychotic drug patient schizophrenia .</brief_summary>
	<brief_title>A Double-blind , Placebo-controlled Trial Donepezil Adjunctive Treatment Cognitive Impairment Schizophrenia</brief_title>
	<detailed_description>The investigator conduct 12-week , double-blind , placebo-controlled trial donepezil adjunctive treatment antipsychotic drug patient schizophrenia.The trial complete 2012 .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>DSMIV diagnosis schizophrenia determine Structured Clinical Interview DSMIV Axis I DisordersClinician Version ; Between 18 40 year age ; Duration illness must longer 2 year ; Patient 's current antipsychotic medication regimen must stable ; Must stable living arrangement ; Patient mental retardation severe organic brain syndrome ; Treatment Electroconvulsive Therapy ( ECT ) within 6 month prior screen ; Has suicidal attempt ideation violent behavior within last 12 month ; Patient history alcohol/drug dependence ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Impaired Cognition Schizophrenia</keyword>
</DOC>